HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS: HTGMQ · Delayed Price · USD
0.0015
0.00 (0.00%)
Apr 18, 2024, 3:46 PM EDT - Market open
HTG Molecular Diagnostics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 12.21 | 9.6 | 22.4 | 7.62 | 8.43 | 9.97 | 7.51 | 3.29 | 3.61 | 1.82 | Upgrade
|
Short-Term Investments | 0 | 12.34 | 6.3 | 25.41 | 22.68 | 0 | 4.3 | 28.2 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 12.21 | 21.94 | 28.7 | 33.03 | 31.11 | 9.97 | 11.81 | 31.5 | 3.61 | 1.82 | Upgrade
|
Cash Growth | -44.35% | -23.53% | -13.12% | 6.16% | 212.12% | -15.61% | -62.49% | 771.63% | 99.05% | -75.19% | Upgrade
|
Receivables | 1.42 | 2.09 | 1.59 | 3.16 | 5.01 | 6.36 | 1.38 | 0.72 | 0.8 | 0.6 | Upgrade
|
Inventory | 0.91 | 1.99 | 1.49 | 1.27 | 1.31 | 1.18 | 1.51 | 2.2 | 1.48 | 0.74 | Upgrade
|
Other Current Assets | 1.11 | 1.16 | 1.09 | 3.9 | 0.57 | 0.44 | 0.43 | 0.45 | 0.11 | 0.16 | Upgrade
|
Total Current Assets | 15.65 | 27.19 | 32.87 | 41.37 | 38 | 17.95 | 15.13 | 34.86 | 6 | 3.33 | Upgrade
|
Property, Plant & Equipment | 1.61 | 2.46 | 2.24 | 3.45 | 2.37 | 3.3 | 3.27 | 1.93 | 1.36 | 1.07 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.6 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 0.52 | 0.81 | 0.09 | 0.3 | 3.4 | 0 | 0.05 | 0.05 | 1.37 | 0 | Upgrade
|
Total Long-Term Assets | 2.13 | 3.27 | 2.33 | 3.75 | 5.77 | 3.31 | 3.32 | 4.59 | 2.73 | 1.07 | Upgrade
|
Total Assets | 17.78 | 30.46 | 35.2 | 45.12 | 43.77 | 21.26 | 18.45 | 39.45 | 8.73 | 4.4 | Upgrade
|
Accounts Payable | 1.16 | 1.65 | 1.35 | 1.66 | 1.85 | 2.44 | 0.76 | 0.72 | 0.95 | 0.75 | Upgrade
|
Deferred Revenue | 2.21 | 0.12 | 0.19 | 0.43 | 0.33 | 0.67 | 0.34 | 0.05 | 0.04 | 0.14 | Upgrade
|
Current Debt | 4.29 | 5.58 | 3.71 | 3.75 | 3.36 | 5.79 | 6.39 | 3.06 | 0.81 | 1.04 | Upgrade
|
Other Current Liabilities | 0.62 | 2.59 | 2 | 3.06 | 1.48 | 4.44 | 2.53 | 2.49 | 1.5 | 0.45 | Upgrade
|
Total Current Liabilities | 8.27 | 9.94 | 7.24 | 8.9 | 7.02 | 13.34 | 10.02 | 6.32 | 3.3 | 2.37 | Upgrade
|
Long-Term Debt | 0.55 | 6.13 | 8.94 | 7.51 | 9.68 | 2.96 | 5.39 | 7.79 | 10.44 | 0.04 | Upgrade
|
Other Long-Term Liabilities | 3.57 | 3.99 | 4.54 | 4.74 | 5.98 | 8.01 | 8.64 | 8.44 | 19.03 | 24.43 | Upgrade
|
Total Long-Term Liabilities | 4.12 | 10.12 | 13.48 | 12.25 | 15.66 | 10.97 | 14.03 | 16.23 | 29.47 | 24.47 | Upgrade
|
Total Liabilities | 12.39 | 20.06 | 20.71 | 21.15 | 22.68 | 24.32 | 24.05 | 22.55 | 32.77 | 26.85 | Upgrade
|
Total Debt | 4.83 | 11.71 | 12.64 | 11.25 | 9.68 | 8.75 | 11.78 | 10.85 | 11.25 | 0.04 | Upgrade
|
Debt Growth | -58.72% | -7.39% | 12.35% | 16.28% | 10.56% | -25.68% | 8.57% | -3.56% | 25398.44% | -78.50% | Upgrade
|
Common Stock | 0 | 0.01 | 0.01 | 0.06 | 0.03 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | Upgrade
|
Retained Earnings | -229.93 | -208.33 | -191.19 | -170.32 | -151.02 | -134.57 | -115.61 | -89.57 | -68.17 | -54.21 | Upgrade
|
Comprehensive Income | 0 | 0 | 0.01 | -0 | -0 | 0 | -0 | -0.04 | 0 | 0 | Upgrade
|
Shareholders' Equity | 5.39 | 10.4 | 14.48 | 23.97 | 21.09 | -3.06 | -5.59 | 16.89 | -24.04 | -22.45 | Upgrade
|
Total Liabilities and Equity | 17.78 | 30.46 | 35.2 | 45.12 | 43.77 | 21.26 | 18.45 | 39.45 | 8.73 | 4.4 | Upgrade
|
Net Cash / Debt | 7.38 | 10.23 | 16.05 | 21.78 | 21.43 | 1.21 | 0.03 | 20.65 | -7.64 | 1.77 | Upgrade
|
Net Cash / Debt Growth | -27.92% | -36.24% | -26.29% | 1.59% | 1665.28% | 3509.41% | -99.84% | - | - | -75.09% | Upgrade
|
Net Cash Per Share | 8.30 | 17.71 | 41.62 | 102.88 | 140.18 | 20.62 | 0.85 | 822.50 | -4123.39 | 956.35 | Upgrade
|
Working Capital | 7.38 | 17.24 | 25.63 | 32.47 | 30.98 | 4.61 | 5.11 | 28.54 | 2.7 | 0.95 | Upgrade
|
Book Value Per Share | 6.06 | 17.99 | 37.56 | 113.24 | 137.94 | -51.97 | -141.53 | 672.99 | -12980.76 | -12121.21 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.